Journal of Cataract & Refractive Surgery
Volume 30, Issue 11 , Pages 2254-2255 , November 2004

Tissue plasminogen activator in the management of anterior chamber fibrin formation

References 

  1. Georgiadis N, Boboridis K, Halvatzis N, et al.  Low-dose tissue plasminogen activator in the management of anterior chamber fibrin formation. J Cataract Refract Surg. 2003;29:729–732
  2. Heiligenhaus A, Steinmetz B, Lapuente R, et al.  Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery (a prospective randomised multicentre study). Br J Ophthalmol. 1998;82:810–815
  3. Mehta JS, Adams GG. Recombinant tissue plasminogen activator following paediatric cataract surgery. Br J Ophthalmol. 2000;84:983–986
  4. Wedrich A, Menapace R, Ries E, Polzer I. Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery. J Cataract Refract Surg. 1997;23:873–877
  5. Erol N, Özer A, Topbaş S, et al.  Treatment of intracameral fibrinous membranes with tissue plasminogen activator. Ophthalmic Surg Lasers Imaging. 2003;34:451–456

PII: S0886-3350(04)00849-1

doi: 10.1016/j.jcrs.2004.08.021

Journal of Cataract & Refractive Surgery
Volume 30, Issue 11 , Pages 2254-2255 , November 2004

Article Tools